Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 40 Projects
Project # Contact PI Funding Organization Fiscal Year
Development of cell free messenger RNA-based non-invasive diagnostic biomarker for Alzheimer's disease
ADDF-54 Sninsky, John Alzheimer's Drug Discovery Foundation 2022
Clinical Implementation of Blood-Based Biomarkers for Alzheimer’s Disease: Clinical Validation, IVD Product Development, and Market Development
ADDF-55 Wilson, David Alzheimer's Drug Discovery Foundation 2022
Measurement of immune cell recruitment as a biomarker of neuroinflammation in Alzheimer's disease and other diseases of the central nervous system
ADDF-32 Menniti, Frank Alzheimer's Drug Discovery Foundation 2021
Plasma pathologic TDP-43 as a biomarker for FTLD-TDP
ADDF-36 Mao, Qinwen Alzheimer's Drug Discovery Foundation 2021
Easy and early plasma pTau181 detection with LUMIPULSE G platform as indicator of Alzheimer's disease
ADDF-38 Vandijck, Manu Alzheimer's Drug Discovery Foundation 2021
Validation and commercialization of a novel blood-based, ultra-multiplex Laboratory Developed Test (LDT) for the prediction of cerebral amyloid status before clinical onset of dementia
ADDF-41 Anderson, Leyla Alzheimer's Drug Discovery Foundation 2021
Plasma neuroinflammatory biomarkers for the diagnossi of dementia subtypes
ADDF-42 Pase, Matthew Alzheimer's Drug Discovery Foundation 2021
Neurofilament (Nf) as a Fluid Biomarker of Neurodegeneration in Familial Frontotemporal Degeneration (f-FTD)
ADDF-46 Horton, Wesley Alzheimer's Drug Discovery Foundation 2021
Blood diagnostic test for AD: aptamer deep biomarker fingerprinting
ADDF-15 Penner, Gregory Alzheimer's Drug Discovery Foundation 2020
Validation of blood based biomarkers for the detection of brain amyloid accumulation before clinical onset of dementia
ADDF-18 Anderson, Leyla Alzheimer's Drug Discovery Foundation 2020